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EIGHTEEN asthmatic children were challenged with ultra-
sonically nebulized cold distilled water (UNCDW). Blood
gas composition was monitored transcutaneously (tcpO
and tcpCO2) during and after the challenge. Assuming as
basal the response to this UNCDW test, nine children
(Group A) were then chosen at random to inhale
cromoglycate by aerosol delivery for 8 days. Nine chil-
dren (Group B), acting as a control, inhaled saline for 8
days. At the end of this therapy, each child repeated the
UNCDW test. Statistical analysis with t-test for paired data
was used to compare the results of each child to both
tests. Mean basal tcpO and tcpCO were all within the
expected normal range. In all children, both mean tcpO
and tcpCO were reduced during and after UNCDW inha-
lation. Mean tcpCO values during the challenge were
significantly (p < 0.001) lower than the corresponding
steady state 2 rain after the UNCDW challenge, with a
mean drop of-7% (2.1 S.D.). MeantcpO values remained
significantly decreased (p < 0.001) from the fifth mitt of
the UNCDW challenge to the end of the observation pe-
riod, with a mean drop of-20% (15.5 S.D.). After treat-
ment with cromoglycate (Group A), the mean tcpCO
values during UNCDW did not change significantly from
those ofsteady state conditions: -0.8% (0.5 S.D.); whereas
mean tcpO values decreased by -4% (4.9 S.D.). The con-
trol children treated with saline (Group B) showed mean
tcpCO and tcpO values which were significantly differ-
ent (p < 0.001) from those of the steady state conditions:
mean drop oftcpCO2, -6% (4.2 S.D.); mean drop oftcpO2,
-20% (4.7 S.D.). In conclusion, it emerges that: UNCDW
induces nonspecific broncho-constriction in asthmatic
children with a typical drop of tcpCO and tcpO2; the
treatment with cromoglycate normalizes the time course
oftcpCO (hyper-reactivity) and reduces dramatically the
drop of tcpO time course (hyper-responsivity) during
and after the UNCDW test.
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Introduction
Experience over the past 20 years has demon-
strated the ability of cromoglycate to function as a
mast cell stabilizer or inhibitor. Cromoglycate can be
so considered among the anti-inflammatory drugs for
asthma because it reduces bronchial hyper-reactivity
and decreases airway hyper-responsiveness."
This study was designed to obtain further informa-
tion on the effect of cromoglycate on the time
courses of transcutaneous oxygen and carbon diox-
ide pressure (tcpO,. and tcpCO2) during bronchial
challenge by ultrasonic nebulized ’cold’ distilled
water (UNCDW)3’4 in children with asthma.
The possibility of performing continuous non-
invasive monitoring of gas composition has been
achieved by means of electrodes for transcutaneous
pO and pCO,. monitoring.
This technique provides an accurate way of moni-
toring gas exchange changes during and after bron-
chial challenge.
The bronchial challenge used is ultrasonically
nebulized cold distilled water (UNCDW), which in-
duces bronchoconstriction in children with asthma.
The method is simple and reproducible, and is char-
acterized by a high degree of specificity.
Materials and Methods
A placebo controlled study was undertaken on 18
asthmatic children (eight males, ten females) aged 3
to 12 years, with bronchial hyper-reactivity. At the
time of the investigation, all children were free of
symptoms and had not received any drug during the
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previous 8 days. Before submitting children to the
study, informed consent was obtained from their
parents.
Transcutaneous oxygen pressure (tcpO2) and car-
bon dioxide (tcpCO2) were monitored by the
Gasthmatic system, after calibration, by placing the
heated monoelectrode (44C) on the upper chest of
each child and allowing a stabilization period of
15-20 min. Baseline data were collected when the
tcpO,, and tcpCO2 had reached a steady state level
and the children were lying quietly without body
movements.
The children were then given the UNCDW test:
ultrasonic nebulizer De Vilbiss Ultra-neb 99 at 5 ml/
min flow for 7 min was used. Cold distilled water was
obtained by freezing it to around 0C, and using it
just at the time of testing. The tcpO,, and tcpCO,.
values were recorded in the 5 min before the chal-
lenge, throughout the challenge procedures, and for
30 min following the end of nebulization.
For statistical purposes, comparisons were made
between the mean values at the steady state level
before nebulization and those measured during 0-5
and 15-30 min after nebulization. A tcpO drop of
over 15% below the baseline was taken as a positive
response.
Assuming the response to UNCDW test as basal,
nine children (Group A) were then chosen at random
to inhale cromoglycate by aerosol delivery for 8 days
(20 mg three times/day). Nine children (Group B)
acted as placebo control, and inhaled saline (2 ml
three times/day) for 8 days.
At the end of this therapy, each child repeated the
UNCDW test. Statistical analysis with t-test for paired
data was used to compare the results for each child
for both tests.
Results
Basal values: The mean basal values for tcpO2 and
tcpCO,, were all within the expected normal range.
There were no significant differences in these base-
line variables between the two groups of subjects.
Response to UNCDW: In all children, both mean tcpO2
and tcpCOa were reduced during and after UNCDW
inhalation. TcpCO decreased immediately after the
start of UNCDW exposure and the decrease was
maximal around the third min of the challenge. The
tcpCO,, level started to pick up again immediately
after the end of the exposure and the recovery was
almost complete 5 min after the UNCDW test, with
tcpCO remaining more or less steady from that point
onwards (Fig. 1).
The tcpO,, time course was quite different, the
decrease beginning at the fourth min of UNCDW
inhalation and reaching the lowest value 4 min after
the end of exposure (Fig. 2). Mean tcpCO2 values
during the challenge were significantly lower than
the corresponding baseline (p < 0.001) 2 min after the
UNCDW challenge, with a mean drop of-7% (2.1
S.D.). Mean tcpO values remained significantly de-
creased (p < 0.001) from the fifth min of the UNCDW
challenge to the end of the observation period, with
a mean drop of-20% (15.5 S.D.).
After treatment with cromoglycate in children of
Group A, the mean tcpCO,, values during UNCDW
were not significantly different from those of steady
state (-0.8% (0.5 S.D.)), whereas mean tcpO2 values
decreased by-4% (4.9 S.D.).
The children treated with saline (Group B) showed
mean tcpCO,, and tcpO2 values which were signifi-
cantly different (p < 0.001) from those of the steady
state (mean drop of tcpCO2-6% (4.2 S.D.)); mean
drop of tcpO2-20% (4.7 S.D.)).
Comparisons made between tcpCO,/O2 data for
each child of Group A to both tests (before and after
therapy), showed a statistically significant difference
(p < 0.001). Between data for each child of Group B,
there were no statistically significant differences to
both tests.
Discussion
The possibility of monitoring blood gases with a
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FIG. 1. Transcutaneous tcpCO time courses in asthmatic children in basal
conditions (no/drug, n= 18), in Group A children (DSCG, n= 9) and in
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FIG. 2. Transcutaneous tcpO2 time courses in asthmatic children in basal
conditions (no/drug, n= 18), in Group A children (DSCG, n=9) and in
Group B children (control, n 9), during and afterUNCDW inhalation (mean
% values).
S40 Mediators of Inflammation. Vo13 (Supplement). 1994Effect of cromoglycate on gas changes
tion in real time of their trends of variation, allowed
us to identify the different bronchial structures in-
volved in the hyper-reactive response.
Furthermore, only in asthmatics does the bronchial
challenge induce an appreciable degree of hypoxia
with a later onset, shifted maximum effect, and
longer duration, indicative of a mismatched ventila-
tion/perfusion ratio.
We could verify that, unlike normal adult subjects,
asthmatics (also free of symptoms), had unusual time
courses..for tcpO and tcpCO2 during UNCDW,
namely: (1) the first phase in which tcpCO decreased
immediately after the start ofUNCDW exposure; and
(2) the second phase in which tcpO,, decreased at
about the fourth min of inhalation, reaching the
lowest value four min after the end of exposure.
It is reasonable to suggest that the initial drop of
tcpCO is linked to the response of the bronchial
mucosa, the first target of the challenge. This allows
us to evaluate the behaviour of the bronchial epithe-
lium which is the seat of inflammation (hyper-reac-
tivity).
The phase following this is the contraction of the
smooth muscle, leading to bronchospasm, and then
to the drop in tcpO2 (hyper-responsivity).
A further demonstration of this behaviour is that
the previous administration of a beta-2 agonist drug
10 min before the challenge was shown to prevent
the occurrence of a hypoxic response to the fog
(effect on the bronchial hyper-responsivity), while
the hypocapnic response remained unchanged.9,1
The treatment with anti-inflammatory drugs
showed (in adults) the gradual normalization of the
time courses of pCO (effect on bronchial hyper-
reactivity).
11
In this study, we obtained the same time courses
of blood gases during the UNCDW test in children as
had been observed in adults; on the other hand, after
treatment with cromoglycate (Group A), a normaliza-
tion of the time course for pCO2 occurred and only
a small decrease of tcpO (not above 10% from
baseline) was observed.
In conclusion, it emerges that: UNCDW induces
nonspecific bronchoconstriction in asthmatic chil-
dren, with a similar time course of blood gases to that
of adults; the treatment with cromoglycate normal-
izes the time course of pCO,. (hyper-reactivity) and
reduces dramatically the drop in the pO,. time course
(hyper-responsivity) during and after the UNCDW
test.
References
1. Bernstein IZ. Cromolyn sodium in the treatment of asthma: coming of age in the
United States. JAllergy Clin Immunol 1985; 76: 381.
2. Griffin MP, MacDonald N, McFadden ER. Short- and long-term effects of cromolyn
sodium the airway reactivity of asthmatics. JAllergy Clin Immuno11983; 71: 331.
3. Allegra L, Bianco S. Non-specific bronchoreactivity obtained with ultrasonic
aerosol of distilled water. EurJ Respir Dis 1980; 61 (Suppl 106): 41-49.
4. Mappa L, Muggeo PG, Torio D, Salerno R, Rigillo N. Bronchial challenge by
ultrasonically nebulized ’cold’ distilled water (UNCDW) in children with asthma.
EurRespirJ Sept 1993; 6 (Suppl 17): 615s-P1980.
5. Dal Negro RW, Zoccatelli O, Turco P, Pomari C, Serra R. Transcutaneous O and
CO monitoring in the evaluation of non-specific bronchial hyper-reactivity. SEP
Newsletter No. 11. Banbury, Oxford: Cheney and Sons, 1987; 5-9.
6. Anderson SD, Schoeffel RE, Finney M. Evaluation of ultrasonically nebulized
solution for provocation testing in patients with asthma. Thorax 1983; 38: 284-291.
7. Armitage P. Statistica medica. In: Metodi Statistici per la Ricerca in Medicina (5th
ed.) Milan: Feltrinelli Ed: 1982; 188-212.
8. Dal Negro R, Allegra L. Blood gas changes during and after nonspecific airway
challenge in asthmatic and normal subject. J Appl Physiol 1989; 2627-2630.
9. Dal Negro R. Abnormal airways responses in atopy. Triangle 1988; :7: 3.
10. Turco P, Dal Negro R, Cogo A, Allegra L. Changes in tcCO time due to
ultrasonically nebulized distilled water (UNDW) in atopics before and after
salbutamol. Eur RespirJ 1989; :a (Suppl): (abstrac0.
11. Dal Negro R. La transizione tra normalit risposta iperrattiva. ItalJ Chest Dis 1989;
43 (Suppl 3): 213-218.
Mediators of Inflammation Vol 3 (Supplement). 1994 $41